GENinCode Plc (LON:GENI – Get Free Report) shares traded down 9.5% during mid-day trading on Thursday . The stock traded as low as GBX 4.75 ($0.06) and last traded at GBX 4.75 ($0.06). 104,045 shares changed hands during trading, a decline of 52% from the average session volume of 214,597 shares. The stock had previously closed at GBX 5.25 ($0.07).
GENinCode Stock Performance
The company has a market cap of £8.41 million, a price-to-earnings ratio of -95.00 and a beta of 0.66. The company has a debt-to-equity ratio of 9.27, a current ratio of 2.60 and a quick ratio of 15.89. The firm’s fifty day moving average price is GBX 6.26 and its 200-day moving average price is GBX 6.94.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Recommended Stories
- Five stocks we like better than GENinCode
- What Are Dividends? Buy the Best Dividend Stocks
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- The Significance of Brokerage Rankings in Stock Selection
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
- Energy and Oil Stocks Explained
- MarketBeat Week in Review – 10/14 – 10/18
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
